CD19-CAR-DNT cells (RJMty19) in patients with relapsed or refractory large B-cell lymphoma: a phase 1, first-in-human study

Xibin Xiao(Second Affiliated Hospital of Zhejiang University), Xi Qiu(Agilent Technologies (United States)), Hui Liu(Second Affiliated Hospital of Zhejiang University), Xian Li(Second Affiliated Hospital of Zhejiang University), Yu Cheng(Tianjin University of Technology), Liming Yang(Hunan Children's Hospital), Guangrong Song, Dan Wang(Peking University), Panpan Chen(Women's Hospital, School of Medicine, Zhejiang University)
EClinicalMedicine
February 29, 2024
10.1016/j.eclinm.2024.102516
Cited by 21

Related Papers

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell Differentiation
|Immunity|2004|1.1k
Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program
|Immunity|2002|1k
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues
|Infection and Immunity|1994|157
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129